RxSight, Inc. RXST
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.95M | -46.64M | -38.94M | -35.73M | -32.25M |
| Total Depreciation and Amortization | 3.54M | 3.32M | 3.27M | 2.89M | 3.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.82M | 26.43M | 25.06M | 23.18M | 21.13M |
| Change in Net Operating Assets | -5.14M | -676.00K | -4.89M | -9.00M | -8.88M |
| Cash from Operations | -22.73M | -17.57M | -15.51M | -18.66M | -16.82M |
| Capital Expenditure | -4.43M | -4.01M | -3.83M | -3.54M | -4.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -685.00K | 8.90M | 20.72M | 31.36M | 31.63M |
| Cash from Investing | -5.12M | 4.88M | 16.89M | 27.82M | 27.57M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.00K | -20.00K | -26.00K | -47.00K | -39.00K |
| Issuance of Common Stock | 2.00M | 3.40M | 3.95M | 5.88M | 9.59M |
| Repurchase of Common Stock | -1.12M | -1.12M | -2.06M | -2.06M | -4.05M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -311.00K |
| Cash from Financing | 859.00K | 2.26M | 1.86M | 3.78M | 5.18M |
| Foreign Exchange rate Adjustments | -11.00K | 0.00 | 3.00K | 6.00K | 15.00K |
| Miscellaneous Cash Flow Adjustments | -1.00K | -1.00K | -1.00K | -- | -- |
| Net Change in Cash | -27.00M | -10.43M | 3.24M | 12.95M | 15.95M |